NYU Langone Hospitals

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Endometrial cancer1 trial
• Head and neck cancer1 trial
• Lung cancer1 trial
• Multiple myeloma1 trial
• Ovarian cancer1 trial

Phase

• Phase 11 trial
• Phase 21 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Celyad Oncology SA1 trial
• Seagen, a wholly owned subsidiary of Pfizer1 trial

Running trials

• Active, not recruiting

  A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

  NCT06003231· Phase 2· Seagen, a wholly owned subsidiary of Pfizer· Source

• Active, not recruiting

  Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma

  NCT04613557· Phase 1· Celyad Oncology SA· Source